CN108220389A - The assay method of urokinase potency - Google Patents
The assay method of urokinase potency Download PDFInfo
- Publication number
- CN108220389A CN108220389A CN201711422157.3A CN201711422157A CN108220389A CN 108220389 A CN108220389 A CN 108220389A CN 201711422157 A CN201711422157 A CN 201711422157A CN 108220389 A CN108220389 A CN 108220389A
- Authority
- CN
- China
- Prior art keywords
- solution
- add
- urokinase
- titer
- bovine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/968—Plasmin, i.e. fibrinolysin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9723—Urokinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供一种尿激酶效价的测定方法,包括以下步骤:步骤1:测定材料的准备;步骤2:测定尿激酶效价;2.1、取试管36支,分成9排,每排4支,置2‑10℃冰浴中,各加牛纤维蛋白原溶液0.3ml,并在每排的试管中分别加入巴比妥‑氯化钠缓冲液0.9、0.8、0.7、0.6ml,再依次在第1至3排中加入标准品溶液0.1、0.2、0.3、0.4ml,在第4至6排中分别加入第1份供试品溶液0.1、0.2、0.3、0.4ml,在第7至9排中分别加入第2份供试品溶液0.1、0.2、0.3、0.4ml。在上述试管中,分别加入混合液0.4ml,立即摇匀,置36.5‑7‑37.5℃水浴中并分别用秒表记录入浴时间,以气泡上升到反应系统体积一半时作为反应终点。The present invention provides a kind of assay method of urokinase titer, comprises the following steps: step 1: the preparation of measuring material; Step 2: measure urokinase titer; 2.1, take 36 test tubes, divide into 9 rows, 4 in each row, Place in an ice bath at 2-10°C, add 0.3ml of bovine fibrinogen solution, and add 0.9, 0.8, 0.7, 0.6ml of barbiturate-sodium chloride buffer solution to each row of test tubes, and then Add 0.1, 0.2, 0.3, 0.4ml of standard solution in rows 1 to 3, add 0.1, 0.2, 0.3, 0.4ml of the first test solution in rows 4 to 6, and add 0.1, 0.2, 0.3, 0.4ml of the first test solution in rows 7 to 9 Add the second part of the test solution 0.1, 0.2, 0.3, 0.4ml respectively. Add 0.4ml of the mixed solution to the above-mentioned test tubes, shake well immediately, place in a water bath at 36.5-7-37.5°C and record the bathing time with a stopwatch, and take the time when the bubbles rise to half the volume of the reaction system as the end point of the reaction.
Description
技术领域technical field
本发明涉及一种尿激酶效价的测定方法。The invention relates to a method for measuring urokinase titer.
背景技术Background technique
尿激酶(简称UK)是由健康人群,新鲜人尿中提供分离纯化后制得的一种碱性蛋白水解物,能激活纤维蛋白溶酶原,使其转化为纤维蛋白溶酶,纤维蛋白溶酶具有较强的蛋白水解能力,而纤维蛋白原在凝血酶的作用下转变为纤维蛋白凝块,此凝块在纤维蛋白溶酶的作用下,被水解成水分子多肽而溶解,根据标准品与供试品溶液溶解的速度,计算尿激酶效价。目前,按《中国药典》2015年版二部532 页尿激酶品种项下,[效价测定-气泡上升法]方法进行检验,存在气泡弱,可观察性差,实验误差大的问题。Urokinase (UK for short) is a kind of basic protein hydrolyzate obtained after separation and purification from healthy people and fresh human urine, which can activate plasminogen and convert it into plasmin, fibrinolytic The enzyme has a strong proteolytic ability, and the fibrinogen is converted into a fibrin clot under the action of thrombin, and the clot is hydrolyzed into a water molecule polypeptide and dissolved under the action of plasmin. Calculate the urokinase titer with the speed of dissolution of the test solution. At present, according to the urokinase variety item on page 532 of the second part of the "Chinese Pharmacopoeia" in 2015 edition, the [potency determination-bubble rise method] method is used for testing, and there are problems of weak bubbles, poor observability, and large experimental errors.
尿激酶的效价测定方法比较多,EP、BP、《中国药典》2015年版均采用的气泡上升法,只有JP采用的是生色底物测定法。气泡上升法用的试剂比较多,大部分试剂是蛋白质与酶,容易变性,反应终点需要肉眼判定,操作要求比较高;生色底物法是尿激酶与底物反应,生成黄色的硝基苯胺,采用紫外分光光度法测定,操作比较简单,但 L-焦谷氨酰甘氨酰-L-精氨酸-对硝基苯胺盐酸盐等试剂很难购买且费用较贵,方法持续性无法保障。There are many methods for measuring the potency of urokinase. EP, BP, and "Chinese Pharmacopoeia" 2015 edition all adopt the bubble rising method, and only JP uses the chromogenic substrate assay method. The bubble rising method uses a lot of reagents, most of which are proteins and enzymes, which are easy to denature, and the end point of the reaction needs to be judged by the naked eye, and the operation requirements are relatively high; the chromogenic substrate method is that urokinase reacts with the substrate to generate yellow nitroaniline , measured by ultraviolet spectrophotometry, the operation is relatively simple, but reagents such as L-pyroglutamylglycyl-L-arginine-p-nitroaniline hydrochloride are difficult to purchase and expensive, and the sustainability of the method cannot Assure.
发明内容Contents of the invention
本发明所要解决的技术问题在于提供一种可观察性强,检验重现性好,实验误差小的尿激酶效价的测定方法。The technical problem to be solved by the present invention is to provide a method for measuring the potency of urokinase with strong observability, good test reproducibility and small experimental error.
本发明提供一种尿激酶效价的测定方法,包括以下步骤:The invention provides a kind of assay method of urokinase potency, comprises the following steps:
步骤1:测定材料的准备Step 1: Preparation of assay materials
1.1、配制三羟甲基氨基甲烷缓冲液,其pH值为9.0;1.1, prepare Tris buffer solution, its pH value is 9.0;
1.2、配制巴比妥-氯化钠缓冲液,其pH值为7.8;1.2, prepare barbiturate-sodium chloride buffer solution, its pH value is 7.8;
1.3、配制牛纤维蛋白原溶液;1.3. Prepare bovine fibrinogen solution;
1.4、配制牛凝血酶溶液;1.4. Prepare bovine thrombin solution;
1.5、配制牛纤维蛋白溶酶原溶液;1.5. Prepare bovine plasminogen solution;
1.6、配制混合液;1.6. Prepare the mixed solution;
1.7、配制标准品溶液;1.7. Prepare standard solution;
1.8、配制供试品溶液;1.8. Prepare the test solution;
步骤2:测定尿激酶效价Step 2: Determination of urokinase titer
2.1、取试管36支,分成9排,每排4支,置2-10℃冰浴中,各加牛纤维蛋白原溶液0.3ml,并在每排的试管中分别加入巴比妥-氯化钠缓冲液0.9、0.8、0.7、0.6ml,再依次在第1至3排中分别加入标准品溶液0.1、0.2、0.3、0.4ml,在第4至6排中分别加入第1份供试品溶液0.1、0.2、0.3、0.4ml,在第7至9排中分别加入第2份供试品溶液 0.1、0.2、0.3、0.4ml,在上述试管中,分别加入混合液0.4ml,立即摇匀,置36.5-7-37.5℃水浴中,并分别用秒表记录入浴时间,以气泡上升到反应系统体积一半时作为反应终点。2.1. Take 36 test tubes, divide them into 9 rows, 4 tubes in each row, place them in an ice bath at 2-10°C, add 0.3ml of bovine fibrinogen solution to each row, and add barbiturate-chloride to each row of test tubes. Sodium buffer solution 0.9, 0.8, 0.7, 0.6ml, then add standard solution 0.1, 0.2, 0.3, 0.4ml in the 1st to 3rd row respectively, add the first test sample in the 4th to 6th row respectively Solution 0.1, 0.2, 0.3, 0.4ml, add the second part of the test solution 0.1, 0.2, 0.3, 0.4ml in the 7th to 9th row, respectively, add 0.4ml of the mixed solution in the above test tube, shake up immediately , put in a water bath at 36.5-7-37.5°C, and record the bathing time with a stopwatch, and take the time when the bubbles rise to half the volume of the reaction system as the end point of the reaction.
进一步地,配制三羟甲基氨基甲烷缓冲液的方法如下:称取三羟甲基氨基甲烷6.06g,盐酸赖氨酸3.65g,氯化钠5.8g,乙二胺四醋酸二钠0.37g,置1000ml烧杯中,加水约900ml使其溶解,在酸度计上用0.1mol/L HCl或0.1mol/LNaOH溶液溶液调节pH值至9.0,最后加水稀释至1000ml,摇匀,即得,贮存2-10℃。Further, the method for preparing tris buffer solution is as follows: weigh 6.06 g of tris, 3.65 g of lysine hydrochloride, 5.8 g of sodium chloride, 0.37 g of disodium edetate, Put it in a 1000ml beaker, add about 900ml of water to dissolve it, adjust the pH value to 9.0 with 0.1mol/L HCl or 0.1mol/L NaOH solution on the pH meter, finally add water to dilute to 1000ml, shake well, and store for 2- 10°C.
进一步地,配制巴比妥-氯化钠缓冲液的方法如下:称取巴比妥钠 5.05g,氯化钠3.7g,置500ml烧杯中,加水约400ml使其溶解,另取明胶0.5g,置50ml烧杯中,加水约30ml,加热溶解后并入上述溶液中,在酸度计上用0.2mol/L HCl液调节pH值至7.8,最后加水稀释至 500ml,摇匀,即得,贮存2-10℃。Further, the method for preparing the barbital-sodium chloride buffer solution is as follows: weigh 5.05 g of barbital sodium and 3.7 g of sodium chloride, put them in a 500 ml beaker, add about 400 ml of water to dissolve them, and take 0.5 g of gelatin in addition, Put it in a 50ml beaker, add about 30ml of water, heat to dissolve, add to the above solution, adjust the pH value to 7.8 with 0.2mol/L HCl solution on the acidity meter, finally add water to dilute to 500ml, shake well, and store for 2- 10°C.
进一步地,配制牛纤维蛋白原溶液的方法如下:取纤维蛋白原(牛血),加入步骤二配制的巴比妥-氯化钠缓冲液,制成每1ml含可凝结蛋白6.67mg的溶液,摇匀,即得,置2-10℃。Further, the method for preparing bovine fibrinogen solution is as follows: take fibrinogen (bovine blood), add the barbiturate-sodium chloride buffer solution prepared in step 2, and make a solution containing 6.67 mg of coagulable protein per 1 ml, Shake well, that is, set at 2-10 ℃.
进一步地,配制牛凝血酶溶液的方法如下:取凝血酶(牛血),加步骤二配制的巴比妥-氯化钠缓冲液,制成每1ml含凝血酶6.0单位的溶液,置2-10℃。Further, the method for preparing bovine thrombin solution is as follows: take thrombin (cow blood), add the barbiturate-sodium chloride buffer solution prepared in step 2, make a solution containing 6.0 units of thrombin per 1 ml, place in 2- 10°C.
进一步地,配制牛纤维蛋白溶酶原溶液的方法如下:取纤维蛋白溶酶原(牛血),加步骤一配制的三羟甲基氨基甲烷缓冲液,制成每 1ml含0.7-1.4酪蛋白单位的溶液,置2-10℃。如制成的溶液浑浊,应离心后取上清液使用。Further, the method for preparing bovine plasminogen solution is as follows: take plasminogen (bovine blood), add the Tris buffer prepared in step 1, and make every 1ml contain 0.7-1.4 casein Unit solution, set at 2-10°C. If the resulting solution is turbid, centrifuge and take the supernatant for use.
进一步地,配制混合液的方法如下:取牛凝血酶溶液与牛纤维蛋白溶酶原溶液等容积混合均匀,置2-10℃。Further, the method for preparing the mixed solution is as follows: Take bovine thrombin solution and bovine plasminogen solution and mix them evenly in equal volumes, and place at 2-10°C.
进一步地,配制标准品溶液的方法如下:取尿激酶标准品1支,加步骤二配制的巴比妥-氯化钠缓冲液,溶解并稀释成约每1ml中含尿激酶约60单位的溶液,置2-10℃。Further, the method for preparing the standard solution is as follows: take 1 standard urokinase, add the barbiturate-sodium chloride buffer solution prepared in step 2, dissolve and dilute it into a solution containing about 60 units of urokinase per 1 ml , set at 2-10°C.
进一步地,配制供试品溶液:取供试品5瓶,置容量瓶中,加步骤二配制的巴比妥-氯化钠缓冲液溶解、混匀,并稀释至与标准品溶液相同的浓度,置2-10℃。Further, prepare the test solution: take 5 bottles of the test product, put them in a volumetric flask, add the barbiturate-sodium chloride buffer solution prepared in step 2 to dissolve, mix, and dilute to the same concentration as the standard solution , set at 2-10°C.
进一步地,以标准品溶液各管浓度的对数值为横座标,反应终点时间与入浴时间的差值对数值为纵座标,计算线性回归方程式,再以供试品各管反应终点时间与入浴时间的差值的对数值输入回归方程式,算出各管的单位数,除以各管的加样量,即得每1ml中单位数,求出平均值,按以下公式计算效价单位数:Further, take the logarithm value of the concentration of each tube of the standard solution as the abscissa, and the logarithm value of the difference between the reaction end time and the bathing time as the ordinate, calculate the linear regression equation, and then take the reaction end time of each tube of the test product and the bathing time as the ordinate. Input the logarithmic value of the time difference into the regression equation, calculate the number of units in each tube, divide by the sample volume of each tube, that is, the number of units per 1ml, find the average value, and calculate the number of titer units according to the following formula:
采用本发明提供的尿激酶效价的测定方法,尿激酶效价检验过程中产生的气泡大、亮、反应终点明显,可观察性强,检验重现性好,实验误差小。By adopting the method for measuring urokinase titer provided by the present invention, the bubbles generated during the test of urokinase titer are large and bright, the reaction end point is obvious, the observability is strong, the test reproducibility is good, and the experimental error is small.
附图说明Description of drawings
此处所说明的附图用来提供对本发明的进一步理解,构成本申请的一部分,本发明的示意性实施例及其说明用于解释本发明,并不构成对本发明的不当限定。在附图中:The accompanying drawings described here are used to provide a further understanding of the present invention and constitute a part of the application. The schematic embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations to the present invention. In the attached picture:
图1示意性示意出本发明实施例3的标准品线性图。Fig. 1 schematically shows the linear diagram of the standard product of Example 3 of the present invention.
具体实施方式Detailed ways
实施例1Example 1
本发明实施例提供一种尿激酶效价的测定方法,包括以下步骤:The embodiment of the present invention provides a method for determining the titer of urokinase, comprising the following steps:
步骤1:测定材料的准备Step 1: Preparation of assay materials
1.1、配制三羟甲基氨基甲烷缓冲液(其pH值为9.0)1.1, prepare Tris buffer solution (its pH value is 9.0)
称取三羟甲基氨基甲烷6.06g,盐酸赖氨酸3.65g,氯化钠5.8g,乙二胺四醋酸二钠0.37g,置1000ml烧杯中,加水约900ml使其溶解,在酸度计上用0.1mol/L HCl或0.1mol/LNaOH溶液溶液调节pH值至 9.0,最后加水稀释至1000ml,摇匀,即得,贮存2-10℃。Weigh 6.06g of trishydroxymethylaminomethane, 3.65g of lysine hydrochloride, 5.8g of sodium chloride, and 0.37g of disodium ethylenediaminetetraacetate, put them in a 1000ml beaker, add about 900ml of water to dissolve them, and put them on the pH meter Use 0.1mol/L HCl or 0.1mol/L NaOH solution to adjust the pH value to 9.0, and finally add water to dilute to 1000ml, shake well, and store at 2-10°C.
1.2、配制巴比妥-氯化钠缓冲液(其pH值为7.8)1.2, prepare barbiturate-sodium chloride buffer solution (its pH value is 7.8)
称取巴比妥钠5.05g,氯化钠3.7g,置500ml烧杯中,加水约400ml 使其溶解,另取明胶0.5g,置50ml烧杯中,加水约30ml,加热溶解后并入上述溶液中,在酸度计上用0.2mol/L HCl液调节pH值至7.8,最后加水稀释至500ml,摇匀,即得,贮存2-10℃。Weigh 5.05g of barbital sodium and 3.7g of sodium chloride, put them in a 500ml beaker, add about 400ml of water to dissolve them, take another 0.5g of gelatin, put them in a 50ml beaker, add about 30ml of water, heat to dissolve and incorporate into the above solution , adjust the pH value to 7.8 with 0.2mol/L HCl solution on the acidity meter, and finally add water to dilute to 500ml, shake well, and store at 2-10°C.
1.3、配制牛纤维蛋白原溶液1.3. Preparation of bovine fibrinogen solution
取纤维蛋白原(牛血),按标签上的标示量,加入步骤二配制的巴比妥-氯化钠缓冲液,制成每1ml含可凝结蛋白6.67mg的溶液,摇匀,即得,置2-10℃。Take fibrinogen (bovine blood), add the barbiturate-sodium chloride buffer solution prepared in step 2 according to the amount indicated on the label, and make a solution containing 6.67 mg of coagulable protein per 1 ml, shake well, and obtain, Set at 2-10°C.
1.4、配制牛凝血酶溶液1.4. Preparation of bovine thrombin solution
取凝血酶(牛血),按标签上的标示量,加步骤二配制的巴比妥- 氯化钠缓冲液,制成每1ml含凝血酶6.0单位的溶液,置2-10℃。Take thrombin (cow blood), add the barbiturate-sodium chloride buffer solution prepared in step 2 according to the amount indicated on the label, to make a solution containing 6.0 units of thrombin per 1 ml, and place at 2-10°C.
1.5、配制牛纤维蛋白溶酶原溶液1.5. Prepare bovine plasminogen solution
取纤维蛋白溶酶原(牛血),按标签上的标示量,加步骤一配制的三羟甲基氨基甲烷缓冲液,制成每1ml含0.7-1.4酪蛋白单位的溶液,置2-10℃。如制成的溶液浑浊,应离心后取上清液使用。Take plasminogen (bovine blood), add the tris buffer solution prepared in step 1 according to the amount indicated on the label, and make a solution containing 0.7-1.4 casein units per 1ml, and place in 2-10 ℃. If the resulting solution is turbid, centrifuge and take the supernatant for use.
1.6、配制混合液1.6. Prepare the mixed solution
临用前取步骤四配制的牛凝血酶溶液与步骤五配制的牛纤维蛋白溶酶原溶液等容积混合均匀,即得,置2-10℃。Before use, take the bovine thrombin solution prepared in step 4 and the bovine plasminogen solution prepared in step 5 and mix them evenly in equal volumes to obtain the product, and place it at 2-10°C.
1.7、配制标准品溶液1.7. Preparation of standard solution
取尿激酶标准品1支,加步骤二配制的巴比妥-氯化钠缓冲液,溶解并稀释成约每1ml中含尿激酶约60单位的溶液,置2-10℃。Take 1 urokinase standard product, add the barbiturate-sodium chloride buffer solution prepared in step 2, dissolve and dilute to a solution containing about 60 units of urokinase per 1 ml, and place at 2-10°C.
1.8、配制供试品溶液1.8. Prepare the test solution
取供试品5瓶,置容量瓶中,加步骤二配制的巴比妥-氯化钠缓冲液溶解、混匀,并稀释至与标准品溶液相同的浓度,置2-10℃。Take 5 bottles of the test product, put them in a volumetric flask, add the barbiturate-sodium chloride buffer solution prepared in step 2 to dissolve, mix evenly, and dilute to the same concentration as the standard solution, and place at 2-10°C.
以上,明胶、尿激酶标准品、纤维蛋白原(牛血)、凝血酶(牛血)、纤维蛋白溶酶原(牛血)为中国药品生物制品检定研究院提供,尿激酶供试品为国内原料及制剂厂家的产品。Above, gelatin, standard urokinase, fibrinogen (bovine blood), thrombin (bovine blood), and plasminogen (bovine blood) were provided by China National Institute for the Control of Pharmaceutical and Biological Products, and urokinase was provided by domestic Products of raw material and preparation manufacturers.
步骤2:测定尿激酶效价Step 2: Determination of urokinase titer
2.1、取试管(12×100mm)36支,分成9排,每排4支,置2-10℃冰浴中,各加牛纤维蛋白原溶液0.3ml,并在每排的试管中分别加入巴比妥-氯化钠缓冲液0.9、0.8、0.7、0.6ml,再依次在第1至3排中分别加入标准品溶液0.1、0.2、0.3、0.4ml,在第4至6排中分别加入第 1份供试品溶液0.1、0.2、0.3、0.4ml,在第7至9排中分别加入第2 份供试品溶液0.1、0.2、0.3、0.4ml。在上述试管中,分别加入混合液 0.4ml,立即摇匀,置36.5-7-37.5℃水浴中,并分别用秒表记录入浴时间,以气泡上升到反应系统体积一半时作为反应终点。2.1. Take 36 test tubes (12×100mm), divide them into 9 rows, 4 tubes in each row, place them in an ice bath at 2-10°C, add 0.3ml of bovine fibrinogen solution to each row, and add barium to each row of test tubes. 0.9, 0.8, 0.7, 0.6ml of Bito-sodium chloride buffer solution, then add standard solution 0.1, 0.2, 0.3, 0.4ml in the 1st to 3rd row respectively, and add the 4th to 6th row respectively Add 0.1, 0.2, 0.3, 0.4ml of 1 portion of test solution, and add 0.1, 0.2, 0.3, 0.4ml of 2nd portion of test solution in the 7th to 9th row respectively. Add 0.4ml of the mixture to the above test tubes, shake well immediately, place in a water bath at 36.5-7-37.5°C, and record the bathing time with a stopwatch, and take the time when the bubbles rise to half the volume of the reaction system as the end point of the reaction.
2.2、以标准品溶液各管浓度的对数值为横座标,反应终点时间与入浴时间的差值对数值为纵座标,计算线性回归方程式,再以供试品各管反应终点时间与入浴时间的差值的对数值输入回归方程式,算出各管的单位数,除以各管的加样量,即得每1ml中单位数,求出平均值,按以下公式计算效价单位数:2.2. Take the logarithm value of the concentration of each tube of the standard solution as the abscissa, and the logarithm value of the difference between the reaction end time and the bathing time as the ordinate, calculate the linear regression equation, and then use the reaction end time and bathing time of each tube of the test product The logarithmic value of the difference is input into the regression equation, the number of units in each tube is calculated, divided by the sample volume of each tube, the number of units per 1ml is obtained, the average value is obtained, and the number of titer units is calculated according to the following formula:
实施例2正交试验Embodiment 2 Orthogonal Test
1、制定正交实验分析表,选取加入试剂放置温度及反应温度对气泡产生量的影响做正交试验,每个因素选取3个水平。1. Formulate an orthogonal experiment analysis table, select the influence of the reagent placement temperature and reaction temperature on the bubble generation to do an orthogonal experiment, and select 3 levels for each factor.
从加入牛纤维蛋白原(F)溶液开始,选择加入试剂后放置温度及反应温度不同,制定正交实验分析表。见表1、表2。Starting from the addition of bovine fibrinogen (F) solution, the temperature and reaction temperature after the addition of reagents are selected to be different, and an orthogonal experimental analysis table is formulated. See Table 1 and Table 2.
表1正交实验表Table 1 Orthogonal experiment table
表2正交实验表Table 2 Orthogonal experiment table
1、选取加入试剂放置温度及反应温度对气泡产生量的影响进行正交试验,每个因素选取3个水平,绘制2因素3水平正交试验表。每次取小试管4支,各加入牛纤维蛋白原溶液0.3ml,分别置正交实验表中序号1-9对应的“加入试剂放置温度”列举的温度中进行水浴,再分别加入巴比妥-氯化钠缓冲液及供试品溶液,最后加入混合液(牛凝血酶溶液和牛纤维蛋白溶酶原溶液),摇匀,放入正交实验表中序号1-9对应的“反应温度”列举的温度中进行反应,分别用秒表记录入浴时间,同时观察试管中凝块内小气泡产生量及上升情况,以气泡上升到反应系统体积一半时作为反应终点,立即计时。1. Select the effect of adding reagent storage temperature and reaction temperature on the amount of air bubbles to conduct an orthogonal experiment, select 3 levels for each factor, and draw a 2-factor 3-level orthogonal test table. Take 4 small test tubes each time, add 0.3ml of bovine fibrinogen solution to each, put them in a water bath at the temperature listed in the "adding reagent storage temperature" corresponding to the serial number 1-9 in the orthogonal experiment table, and then add barbiturate respectively -sodium chloride buffer solution and need testing solution, add mixed solution (bovine thrombin solution and bovine plasminogen solution) at last, shake up, put into the "reaction temperature" corresponding to sequence number 1-9 in the orthogonal experiment table Carry out the reaction at the listed temperature, record the time of bathing with a stopwatch, and observe the amount and rise of small bubbles in the clot in the test tube at the same time. When the bubbles rise to half the volume of the reaction system as the end of the reaction, time it immediately.
表3正交实验结果Table 3 Orthogonal experiment results
由正交结果可以看出,两种因素对尿激酶效价测定过程中气泡产生量影响的显著次序为:加入试剂放置温度>反应温度,并得出最佳实验条件为:加入试剂放置的最佳温度为2-10℃,反应最佳温度为 36.5-7-37.5℃。It can be seen from the orthogonal results that the significant order of the influence of the two factors on the amount of bubbles produced during the determination of the urokinase titer is: adding the reagent and placing it >reaction temperature, and the best experimental conditions are: adding the reagent and placing it the most The optimum temperature is 2-10°C, and the optimum reaction temperature is 36.5-7-37.5°C.
实施例3重复性试验Embodiment 3 repeatability test
采用实施例2更改后的水浴方式对9批样品分别在不同时间段进行了6次实验,标准品的相关性均大于0.9997,样品最大的RSD为1.6%,最小为0.5%,参照图1。The water bath mode after the modification of Example 2 was used to carry out 6 experiments on 9 batches of samples at different time periods. The correlation of the standard items was all greater than 0.9997, and the maximum RSD of the samples was 1.6%, and the minimum was 0.5%. Refer to Figure 1.
表4注射用尿激酶效价重复性结果Table 4 urokinase titer repeatability results for injection
从以上描述可以看出,按照实施例1中的测定尿激酶效价的方法,尿激酶效价检验过程中产生的气泡大、亮、反应终点明显,可观察性强,检验重现性好,实验误差小。As can be seen from the above description, according to the method for measuring the urokinase titer in Example 1, the bubbles produced in the urokinase titer test process are large, bright, and the reaction end point is obvious, the observability is strong, and the test reproducibility is good. The experimental error is small.
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and changes. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711422157.3A CN108220389A (en) | 2017-12-25 | 2017-12-25 | The assay method of urokinase potency |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711422157.3A CN108220389A (en) | 2017-12-25 | 2017-12-25 | The assay method of urokinase potency |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108220389A true CN108220389A (en) | 2018-06-29 |
Family
ID=62648844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711422157.3A Pending CN108220389A (en) | 2017-12-25 | 2017-12-25 | The assay method of urokinase potency |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108220389A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006068469A1 (en) * | 2004-12-23 | 2006-06-29 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Methods for the functional determination of mannan-binding-lectin associated serine proteases (masps) and complexes thereof |
US20110293529A1 (en) * | 2010-05-06 | 2011-12-01 | Tao Ji | Fluorescent nirf activatable probes for disease detection |
CN104906054A (en) * | 2015-06-15 | 2015-09-16 | 武汉人福药业有限责任公司 | Preparation method of lyophilized urokinase preparation |
-
2017
- 2017-12-25 CN CN201711422157.3A patent/CN108220389A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006068469A1 (en) * | 2004-12-23 | 2006-06-29 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Methods for the functional determination of mannan-binding-lectin associated serine proteases (masps) and complexes thereof |
US20110293529A1 (en) * | 2010-05-06 | 2011-12-01 | Tao Ji | Fluorescent nirf activatable probes for disease detection |
CN104906054A (en) * | 2015-06-15 | 2015-09-16 | 武汉人福药业有限责任公司 | Preparation method of lyophilized urokinase preparation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107118865B (en) | Cleaning solution | |
CN104198724B (en) | Fibrin or fibrinogen degradation product (FDP) detection kit | |
CN104360072B (en) | A D-dimer latex-enhanced immune turbidimetric detection kit used in conjunction with an ion stabilizer and a suspension stabilizer | |
CN106198415A (en) | A kind of test kit measuring glycolated hemoglobin and preparation method thereof | |
JP6198821B2 (en) | Euglobulin-based method for determining the biological activity of defibrotide | |
CN102636653A (en) | Compounded latex particle-enveloped cystatin C detection kit | |
CN102081100B (en) | Liver cancer multi-marker micro-array kit as well as preparation method and application thereof | |
ES2381334T3 (en) | Immunological latex turbidimetry procedures and reagent for it | |
CN103645323A (en) | Cystatin C detection kit and preparation method therefor | |
CN102964428B (en) | Kit for detecting soluble leukocyte differentiation antigen 40 ligand and polypeptide ligand | |
CN106290871B (en) | A kind of latex enhancing immune turbidimetry kit for being used to detect SOD in serum | |
CN109142335A (en) | The kit and its detection method of spatial neighbor chemoluminescence method detection Procalcitonin | |
CN104215771B (en) | A kind of High-sensitivity C reactive protein detection kit of amplifying based on liposome signal | |
CN106645751B (en) | A kind of fibrinogen content detection kit | |
CN108220389A (en) | The assay method of urokinase potency | |
CN104698159B (en) | A kind of detection method of endotoxin content | |
CN109486901B (en) | Method for detecting glutamine transaminase in minced fillet product | |
CN114295840B (en) | Kit for high-sensitivity quantitative determination of adiponectin and preparation method thereof | |
CN113913491B (en) | Determination method of protein C activity, reagents for determination and preparation method | |
CN106645749B (en) | Hemolytic agent and application | |
CN106093419A (en) | A kind of mensuration dimeric test kit of D and preparation method thereof | |
US11774455B2 (en) | Peptide aptamer for specific recognition of arginine and its application | |
CN104906054B (en) | A kind of freeze-dried preparation method of urokinase | |
CN108445212A (en) | A kind of colloidal gold strip and kit for detecting clostridium difficile | |
CN113791223A (en) | Immunoturbidimetric kit for detecting alpha 1-antitrypsin and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180629 |